• 2024
  Zongo PD, Cabanel N, Royer G, Depardieu F, Hartmann A, Naas T, Glaser P, Rosinski-Chupin I, An antiplasmid system drives antibiotic resistance gene integration in carbapenemase-producing Escherichia coli lineages., Nat Commun 2024 May; 15(1): 4093.
• 2023
  Plainvert C, Rosinski-Chupin I, Weckel A, Lambert C, Touak G, Sauvage E, Poyart C, Glaser P, Fouet A, A Novel CovS Variant Harbored by a Colonization Strain Reduces Streptococcus pyogenes Virulence., J Bacteriol 2023 Apr; 205(4): e0003923.
• 2022
  Patiño-Navarrete R, Rosinski-Chupin I, Cabanel N, Zongo PD, Héry M, Oueslati S, Girlich D, Dortet L, Bonnin RA, Naas T, Glaser P, , Specificities and Commonalities of Carbapenemase-Producing Escherichia coli Isolated in France from 2012 to 2015., mSystems 2022 Jan; (): e0116921.
• 2021
  Mazzuoli MV, Daunesse M, Varet H, Rosinski-Chupin I, Legendre R, Sismeiro O, Gominet M, Kaminski PA, Glaser P, Chica C, Trieu-Cuot P, Firon A, , The CovR regulatory network drives the evolution of Group B Streptococcus virulence., PLoS Genet 2021 Sep; 17(9): e1009761.
• 2021
  Cabanel N, Rosinski-Chupin I, Chiarelli A, Botin T, Tato M, Canton R, Glaser P, , Evolution of VIM-1-Producing Klebsiella pneumoniae Isolates from a Hospital Outbreak Reveals the Genetic Bases of the Loss of the Urease-Positive Identification Character., mSystems 2021 Jun; (): e0024421.
• 2020
  Chiarelli A, Cabanel N, Rosinski-Chupin I, Zongo PD, Naas T, Bonnin RA, Glaser P, , Diversity of mucoid to non-mucoid switch among carbapenemase-producing Klebsiella pneumoniae., BMC Microbiol 2020 Oct; 20(1): 325.
• 2020
  Patiño-Navarrete R, Rosinski-Chupin I, Cabanel N, Gauthier L, Takissian J, Madec JY, Hamze M, Bonnin RA, Naas T, Glaser P, , Stepwise evolution and convergent recombination underlie the global dissemination of carbapenemase-producing Escherichia coli., Genome Med 2020 01; 12(1): 10.
• 2019
  Rosinski-Chupin I, Sauvage E, Fouet A, Poyart C, Glaser P, , Conserved and specific features of Streptococcus pyogenes and Streptococcus agalactiae transcriptional landscapes., BMC Genomics 2019 Mar; 20(1): 236.
• 2018
  Jousset AB, Bonnin RA, Rosinski-Chupin I, Girlich D, Cuzon G, Cabanel N, Frech H, Farfour E, Dortet L, Glaser P, Naas T, , A 4.5-Year Within-Patient Evolution of a Colistin-Resistant Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Sequence Type 258., Clin Infect Dis 2018 10; 67(9): 1388-1394.
• 2018
  Jousset AB, Rosinski-Chupin I, Takissian J, Glaser P, Bonnin RA, Naas T, , Transcriptional Landscape of a blaKPC-2 Plasmid and Response to Imipenem Exposure in Escherichia coli TOP10., Front Microbiol 2018 ; 9(): 2929.
• 2017
  Almeida A, Rosinski-Chupin I, Plainvert C, Douarre PE, Borrego MJ, Poyart C, Glaser P, , Parallel Evolution of Group B Streptococcus Hypervirulent Clonal Complex 17 Unveils New Pathoadaptive Mutations., mSystems ; 2(5): .
• 2015
  Almeida A, Villain A, Joubrel C, Touak G, Sauvage E, Rosinski-Chupin I, Poyart C, Glaser P, Whole-Genome Comparison Uncovers Genomic Mutations between Group B Streptococci Sampled from Infected Newborns and Their Mothers, J. Bacteriol. 2015 Oct;197(20):3354-66.
• 2015
  Rosinski-Chupin I Sauvage E, Sismeiro , Villain A, Da Cunha V, Caliot M, Dillies MA, Trieu-Cuot P, Bouloc P, Lartigue MF, Glaser P., Single nucleotide resolution RNA-seq uncovers new regulatory mechanisms in the opportunistic pathogen Streptococcus agalactiae., BMC Genomics. 2015 May 30;16:419.
• 2014
  Da Cunha V, Davies MR, Douarre PE, Rosinski-Chupin I, Margarit I, Spinali S, Perkins T, Lechat P, Dmytruk N, Sauvage E, Ma L, Romi B, Tichit M, Lopez-Sanchez MJ, Descorps-Declere S, Souche E, Buchrieser C, Trieu-Cuot P, Moszer I, Clermont D, Maione D, Bouchier C, McMillan DJ, Parkhill J, Telford JL, Dougan G, Walker MJ, , Holden MTG, Poyart C, Glaser P, , Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline., Nat Commun 2014 Aug; 5(): 4544.
• 2014
  Da Cunha V, Davies MR, Douarre PE, Rosinski-Chupin I, Margarit I, Spinali S, Perkins T, Lechat P, Dmytruk N, Sauvage E, Ma L, Romi B, Tichit M, Lopez-Sanchez MJ, Descorps-Declere S, Souche E, Buchrieser C, Trieu-Cuot P, Moszer I, Clermont D, Maione D, Bouchier C, McMillan DJ, Parkhill J, Telford JL, Dougan G, Walker MJ; DEVANI Consortium, Holden MT, Poyart C, Glaser P., Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline., Nat Commun. 2014 Aug 4;5:4544 Erratum in : Nat Commun. 2015; 6:6108.
• 2012
  Lopez-Sanchez MJ, Sauvage E, Da Cunha V, Clermont D, Ratsima Hariniaina E, Gonzalez-Zorn B, Poyart C, Rosinski-Chupin I, Glaser P, , The highly dynamic CRISPR1 system of Streptococcus agalactiae controls the diversity of its mobilome., Mol Microbiol 2012 Sep; 85(6): 1057-71.